Malignant gastric germ cell tumor

Summary

Malignant gastric germ cell tumor (MONDO:0003112) is a cancer. A subtype of gastric cancer — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	malignant gastric germ cell tumor
Mondo ID	MONDO:0003112
DOID	DOID:4716
NCIT	C5486
UMLS	C1334584
MedGen	233663
GARD	0023370
Anatomy (UBERON)	UBERON:0000945
Is cancer (heuristic)	yes

Also known as: malignant gastric germ cell neoplasm · malignant gastric germ cell tumor · malignant germ cell neoplasm of stomach · malignant germ cell neoplasm of the stomach · malignant germ cell tumor of stomach · malignant germ cell tumor of the stomach · malignant germ cell tumour of stomach · malignant germ cell tumour of the stomach

Disease family

This is a subtype of gastric cancer. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorder › digestive system cancer › gastric cancer › malignant gastric germ cell tumor

Related subtypes (8): malignant gastric granular cell tumor, gastric lymphoma, pylorus cancer, cardia cancer, gastric leiomyosarcoma, gastric liposarcoma, gastric carcinoma, diffuse gastric cancer

Subtypes (2): immature gastric teratoma, gastric choriocarcinoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.